The global chemical market offers a vast array of compounds essential for industrial and scientific advancement. Among these, 6-Hydroxy-3,4-dihydro-1H-quinolin-2-one (CAS 54197-66-9) holds significant importance, primarily as a pharmaceutical intermediate. Its utility in the synthesis of drugs like Cilostazol, and its role as a key metabolite, make it a compound of interest for many companies in the life sciences sector.

Professionals seeking to acquire this chemical need to be informed about its typical specifications. 6-Hydroxy-3,4-dihydro-1H-quinolin-2-one is generally presented as a white to tan powder or crystalline solid, with a melting point typically between 236-240°C. Its molecular formula C9H9NO2 and molecular weight of 163.17 are standard identifiers. High purity, often exceeding 95% by HPLC, is a critical quality parameter that discerning buyers will look for.

The primary application of this compound is as a building block in pharmaceutical synthesis. Its association with Cilostazol, a medication used to treat peripheral vascular disease, underscores its value in the production of cardiovascular therapies. Furthermore, its status as a metabolite provides researchers with a vital tool for studying drug pharmacokinetics and metabolism, contributing to a deeper understanding of drug action and safety profiles.

For companies looking to purchase 6-Hydroxy-3,4-dihydro-1H-quinolin-2-one, identifying reliable global suppliers is key. The market offers numerous manufacturers, with a notable presence of providers in China known for their competitive pricing and manufacturing capabilities. When engaging with potential suppliers, it is recommended to request detailed product specifications, Certificates of Analysis, and MSDS documents to ensure quality and compliance. Understanding the nuances of the market, including current pricing trends and lead times for delivery, will enable strategic sourcing for research and manufacturing needs. By working with trusted chemical manufacturers, organizations can secure a consistent and high-quality supply of this essential pharmaceutical intermediate.